Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice

Learning and Memory

Volumn 16, Issue 1, 2009, Pages 28-37

  Labrie, Viviane ^a,b   Duffy, Steven ^a   Wang, Wei ^c   Barger, Steven W ^c,d   Baker, Glen B ^e   Roder, John C ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO AMINO ACID OXIDASE; DEXTRO SERINE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITION; CONDITIONING; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; GENE MUTATION; HETEROZYGOTE; LEARNING; MALE; MAZE TEST; MEMORY; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; BRAIN; D-AMINO-ACID OXIDASE; EXTINCTION, PSYCHOLOGICAL; MAZE LEARNING; MICE; MICE, INBRED C57BL; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSAL LEARNING; SERINE;

EID: 58149343968     PISSN: 10720502     EISSN: 15495485     Source Type: Journal    
DOI: 10.1101/lm.1112209     Document Type: Article

References (70)

1. Almond, S.L., Fradley, R.L., Armstrong, E.J., Heavens, R.B., Rutter, A.R., Newman, R.J., Chiu, C.S., Konno, R., Hutson, P.H., and Brandon, N.J. 2006. Behavioral and biochemical characterization of a mutant mouse strain lacking D-amino acid oxidase activity and its implications tor schizophrenia. Mol. Cell. Neurosci. 32: 324-334.
2. Andersen, J.D. and Pouzet, B. 2004. Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine. Neuropsychopharmacology 29: 1080-1090.
3. Bauer, D., Hamacher, K., Bröer, S., Pauleit, D., Palm, C., Zilles, K., Coenen, H.H., and Langen, K.J. 2005. Preferred stereoselective brain uptake of D-serine-a modulator of glutamatergic neurotransmission. Nucl. Med. Biol. 32: 793-797.
4. Ben Mamou, C., Gamache, K., and Nader, K. 2006, NMDA receptors are critical for unleashing consolidated auditory fear memories. Nat. Neurosci. 9: 1237-1239.
5. Bonn, L.M., Lefkowitz, R.J., and Caron, M.G. 2002. Differential mechanisms of morphine antinociceptive tolerance revealed in β-arrestin-2 knockout mice. J. Neurosci. 22: 10494-10500.
6. Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., La Rosa, P., et al. 2002. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. 99: 13675-13680.
7. Clapcote, S.J., Lazar, N.L., Bechard, A.R., and Roder, J.C. 2005. Effects of the rd1 mutation and host strain on hippocampal learning in mice. Behav. Genet. 35: 591-601. Clements, J.D. and Westbrook, G.L. 1991. Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyi-D-aspartate receptor. Neuron 7: 605-613.
8. Coyle, J.T. and Tsai, G. 2004. The NMDA receptor glycine modulatory site: A therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology 174: 32-38.
9. Dalton, G.L., Wang, Y.T., Floresco, S.B., and Phillips, A.G. 2007, Disruption of AMPA receptor endocytosis impairs the extinction, but not acquisition of learned fear, Neuropsychopharmacology 33: 2416-2426.
10. Davis, M., Ressler, K., Rothbaum, B.O., and Richardson, R. 2006. Effects of D-cycloserine on extinction: Translation from preclinical to clinical work. Biol. Psychiatry 60: 369-375.
11. Duffy, S., Labrie, V., and Roder, J.C. 2008. D-Serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning. Neuropsychopharmacology 33: 1004-1018.
12. Foltyn, V.N., Bendikov, I., De Miranda, J., Panizzutti, R., Dumin, E., Shleper, M., Li, P., Toney, M.D., Kartvelishvily, E., and Wolosker, H. 2005. Serine racemase modulates intracellular D-serine levels through an β-elimination activity, J. Biol. Chem. 280: 1754-1763.
13. Fuchs, S.A., Berger, R., Klomp, L.W., and de Koning, T.J. 2005. D-amino acids in the central nervous system in health and disease. Mol. Genet. Metab. 85: 168-180.
14. Grant, S.L., Shulman, Y., Tibbo, P., Hampson, D.R., and Baker, G.B. 2006. Determination of D-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 844: 278-282.
15. Graves, L.A., Heller, E.A., Pack, A.I., and Abel, T. 2003. Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning. Learn. Mem. 10: 168-176.
16. Hashimoto, A., Nishikawa, T., Konno, R., Niwa, A., Yasumura, Y., Oka, T., and Takahashi, K. 1993. Free D-serine, D-aspartate and D-alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase. Neurosci. Lett. 152: 33-36.
17. Hashimoto, K., Fukushima, T., Shimizu, E., Komatsu, N., Watanabe, H., Shinoda, N., Nakazato, M., Kumakiri, C., Okada, S., Hasegawa, H., et al. 2003. Decreased serum levels of D-serine in patients with schizophrenia: Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry 60: 572-576.
18. Hashimoto, K., Engberg, G., Shimizu, E., Nordin, C., Lindstrom, L.H., and Iyo, M. 2005. Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 29: 767-769.
19. Heresco-Levy, U., Javitt, D.C., Ebstein, R., Vass, A., Lichtenberg, P., Bar, G., Catinari, S., and Ermilov, M., 2005. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol. Psychiatry 57: 577-585.
20. Higgins, G.A., Ballard, T.M., Huwyler, J., Kemp, J.A., and Gill, R. 2003. Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: Evidence for an involvement of NR2B NMDA receptors in response inhibition. Neurophurmacology 44: 324-341.
21. Holland, P.C. and Bouton, M.E. 1999. Hippocampus and context in classical conditioning, Curr. Opin. Neurohiol. 9: 195-202.
22. Javitt, D.C. and Zukin, S.R. 1991. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148: 1301-1308.
23. Johnson, J.W. and Ascher, P. 1987. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325: 529-531.
24. Kehoe, E.J., Macrae, M., and Hutchinson, C.L. 1996. MK-801 protects conditioned response from extinction in the rabbit nictitating membrane preparation. Psychobiology 24: 127-135.
25. Kemp, A. and Manahan-Vaughan, D. 2004. Hippocampal long-term depression and long-term potentiation encode different aspects of novelty acquisition. Proc. Natl. Acad. Sci. 101: 8192-8197.
26. Konno, R. and Yasumura, Y. 1983. Mouse mutant deficient in D-amino acid oxidase activity. Genetics 103: 277-285.
27. Krystal, J.H., Karper, L.P., Seibyl, J.P., Freeman, G.K., Delaney, R., Bremner, J.D., Heninger, G.R., Bowers Jr., M.B., and Charney, D.S. 1994. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51: 199-214.
28. Krystal, J.H., Bennett, A., Abi-Saab, D., Belger, A., Karper, L.P., D'Souza, D.C, Lipschitz, D., Abi-Dargham, A., and Charney, D.S. 2000. Dissociation of ketamine effects on rule acquisition and rule implementation: Possible relevance to NMDA receptor contributions to executive cognitive functions. Biol. Psychiatry 47: 137-143.
29. Ledgerwood, L., Richardson, R., and Cranney, J, 2005. D-cycloserine facilitates extinction of learned fear: Effects on reacquisition and generalized extinction. Biol. Psychiatry 57: 841-847.
30. Lee, H. and Kim, J.J. 1998, Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats. J. Neurosci. 18: 8444-8454.
31. Maekawa, M., Okamura, T., Kasai, N., Hori, Y., Summer, K.H., and Konno, R. 2005a. D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity. Chem. Res. Toxicol. 18: 1678-1682.
32. Maekawa, M., Watanabe, M., Yamaguchi, S., Konno, R., and Hori, Y. 2005b. Spatial learning and long-term potentiation of mutant mice lacking D-amino-acid oxidase. Neurosci. Res. 53: 34-38.
33. Malleret, G., Hen, R., Guillou, J.L., Segu, L., and Buhot, M.C. 1999. 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze. J. Neurosci. 19: 6157-6168.
34. Manahan-Vaughan, D. and Braunewell, K.H, 1999. Novelty acquisition is associated with induction of hippocampal long-term depression. Proc. Natl. Acad. Sci. 96: 8739-8744.
35. Martineau, M., Baux, G., and Mothet, J.P, 2006. D-serine signalling in the brain: Friend and foe. Trends Neurosci. 29: 481-491.
36. Matsui, T., Sekiguchi, M., Hashimoto, A., Toniita, U., Nishikawa, T., and Wada, K.J. 1995. Functional comparison of D-serine and giycine in rodents: The effects on cloned NMDA receptors and the extracellular concentration. J. Neurochem. 65: 454-458.
37. Millan, M.J. 2005. N-methyl-D-aspartate receptors as a target for improved antipsychotic agents: Novel insights and clinical perspectives. Psychopharmacology 179: 30-53.
38. Moreno, S., Nardacci, R., Cimini, A., and Ceru, M.P. 1999. Immunocytochemical localization of D-amino acid oxidase in rat brain. J. Neurocytol. 28: 169-185.
39. Morice, E., Billard, J.M., Denis, C., Mathieu, F., Betancur, C., Epelbaum, J., Giros, B., and Nosten-Bertrand, M. 2007. Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia. Neuropsychopharmacology 32: 2108-2116.
40. Mothet, J.P., Parent, A.T., Wolosker, H., Brady Jr., R.O., Linden, D.J., Ferris, C.D., Rogawski, M.A., and Snyder, S.H. 2000. D-serine is an endogenous ligand for the giycine site of the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. 97: 4926-4931.
41. Morita, Y., Ujike, H., Tanaka, Y., Otani, K., Kishimoto, M., Morio, A., Kotaka, T., Okahisa, Y., Matsushita, M., Morikawa, A., et al. 2007. A genetic variant of the serine racemase gene is associated with schizophrenia. Biol. Psychiatry 61: 1200-1203.
42. Nicoll, R.A. 2003. Expression mechanisms underlying long-term potentiation: A postsynaptic view. Philos. Trans. R. Soc. Land. B Biol. Sci. 358: 721-726.
43. Nicholls, R.E., Alarcon, J.M., Malleret, G., Carroll, R.C., Grody, M., Vronskaya, S., and Kandel, E.R. 2008. Transgenic mice lacking NMDAR-dependent LID exhibit deficits in behavioral flexibility. Neuron 58: 104-117.
44. Norberg, M.M., Krystal, J.H., and Tolin, D.F. 2008. A meta-analysis of D- cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry 63: 1118-1126.
45. Pantelis, C., Barber, F.Z., Barnes, T.R., Nelson, H.E., Owen, A.M., and Robbins, T.W. 1999. Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr. Res. 37: 251-270.
46. Pitkänen, M., Sirviö, J., MacDonald, E., Ekonsalo, T., and Riekkinen Sr., P. 1995. The effects of D-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine- treated rats. J. Neural Transm. Park. Dis. Dement. Sect. 9: 133-144.
47. Ressler, K.J., Rothbaum, B.O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., and Davis, M. 2004. Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch. Gen. Psychiatry 61: 1136-1144.
48. Sasaki, M., Konno, R., Nishio, M., Niwa, A., Yasumura, Y., and Enami, J. 1992. A single-base-pair substitution abolishes D-amino-acid oxidase activity in the mouse. Biochim. Biophys. Acta 1139: 315-318.
49. Schell, M.J., Molliver, M.E., and Snyder, S.H. 1995. D-serine, an endogenous synaptic modulator: Localization to astrocytes and glutamate-stimulated release. Proc. Natl. Acad. Sci. 92: 3948-3952.
50. Schell, M.J., Brady Jr., R.O., Molliver, M.E., and Snyder, S.H. 1997. D-serine as a neuromodulator: Regional and developmental localizations in rat brain glia resemble NMDA receptors. J. Neurosci. 17: 1604-1615.
51. Schumacher, J., Jamra, R.A., Freudenberg, J., Becker, T., Ohlraun, S., Otte, A.C., Tullius, M., Kovalenko, S., Bogaert, A.V., Maier, W., et al. 2004. Examination of G72 and D-amino acid oxidase as genetic risk factor for schizophrenia and bipolar affective disorder. Mol. Psychiatry 9: 203-207.
52. Shoji, K., Mariotto, S., Ciampa, A.R., and Suzuki, H. 2006. Mutual regulation between serine and nitric oxide metabolism in human glioblastoma cells. Neurosci. Lett. 394: 163-167.
53. Sotres-Bayon, E., Bush, D.E., and LeDoux, J.E. 2007. Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala. Neuropsychopharmacology 32: 1929-1940.
54. Szapiro, G., Vianna, M.R., McGaugh, J.L., Medina, J.H., and Izquierdo, I. 2003. The role of NMDA glutamate receptors, PKA, MAPK, and CAMKII in the hippocampus in extinction of conditioned fear. Hippocampus 13: 53-58.
55. Tang, Y.P., Shimizu, E., Dube, G.R., Rampon, C., Kerchner, G.A., Zhuo, M., Liu, G., and Tsien, J.Z. 1999. Genetic enhancement of learning and memory in mice. Nature 401: 63-69.
56. Tronson, N.C. and Taylor, J.R. 2007. Molecular mechanisms of memory reconsolidation. Nat Rev. Neurosci. 8: 262-275.
57. Tsai, G., Yang, P., Chung, L.-C., Lange, N., and Coyle, J.T. 1998. D-serine added to antipsychotics for the treatment of schizophrenia. Biol. Psychiatry 44: 1081-1089.
58. 2 mice. Learn. Mem. 5: 391-403.
59. van der Meulen, J.A., Bilbija, L., Joosten, R.N., de Bruin, J.P., and Feenstra, M.G. 2003. The NMDA-receptor antagonist MK-801 selectively disrupts reversal learning in rats. Neuroreport 14: 2225-2228.
60. Wake, K., Yamazaki, H., Hanzawa, S., Konno, R., Sakio, H., Niwa, A., and Hori, Y. 2001. Exaggerated responses to chronic nociceptive stimuli and enhancement of N-methyl-D-aspartate receptor-mediated synaptic transmission in mutant mice lacking D-amino-acid oxidase. Neurosci. Lett. 297: 25-28.
61. Wass, C., Svensson, L., Fejgin, K., Palsson, E., Archer, T., Engel, J.A., and Klamer, D. 2008. Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive flexibility. Pharmacol. Biochem. Behav. 89: 352-359.
62. Watanabe, Y., Himi, T., Saito, H., and Abe, K. 1992. Involvement of giycine site associated with the NMDA receptor in hippocampal long-term potentiation and acquisition of spatial memory in rats. Brain Res. 582: 58-64.
63. Whishaw, I.Q. and Tomie, J.A. 1997. Perseveration on place reversals in spatial swimming pool tasks: Further evidence for place learning in hippocampal rats. Hippocampus 7: 361-370.
64. Wolosker, H., Sheth, K.N., Takahashi, M., Mothet, J., Brady Jr., R.O., Ferris, CD., and Snyder, S.H. 1999. Purification of serine racemase: Biosynthesis of the neuromodulator d-serine. Proc. Natl. Acad. Sci. 96: 721-725.
65. Wong, G.T. 2002. Speed congenics: Applications for transgenic and knockout mouse strains. Neuropeptides 36: 230-236.
66. Wu, S.Z., Bodies, A.M., Porter, M.M., Griffin, W.S., Basile, A.S., and Barger, S.W. 2004. Induction of serine racemase expression and D-serine release from microglia by amyloid β-peptide. J. Neuroinflammation 1: 2. doi: 10.1186/1742-2094-1-2.
67. Yang, Y., Ge, W., Chen, Y., Zhang, Z., Shen, W., Wu, C, Poo, M., and Duan, S. 2003. Contribution of astrocytes to hippocampal long-term potentiation through release of d-serine. Proc. Natl. Acad. Sci. 100: 15194-15199.
68. Young, E.J., Lipina, T., Tam, E., Mandel, A., Clapcote, S.J., Bechard, A.R., ChambersJ., Mount, H.T., Fletcher, P.J., Roder, J.C., et al. 2008. Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1 targeted mice. Genes Brain Behav. 7: 224-234.
69. Zeng, H., Chattarji, S., Barbarosie, M., Rondi-Reig, L., Philpot, B.D., Miyakawa, T., Bear, M.R, and Tonegawa, S. 2001. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Ceil 107: 617-629.
70. Zhang, Z., Gong, N., Wang, W., Xu, L., and Xu, T.L. 2008. Bell-shaped D-serine actions on hippocampal long-term depression and spatial memorv retrieval. Cereb. Cortex 18: 2391-2401.